Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,425.00p
   
  • Change Today:
      5.00p
  • 52 Week High: 4,750.00
  • 52 Week Low: 2,400.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 5,063
  • Market Cap: £126.58m
  • Beta: 0.00

Latest Deals

Traded Action Notifier PriceAmountValue
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00
29-Apr-24 Buy Bruce Hiscock 4,552.00p 11 £500.72

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
29-Apr-24 Buy Bruce Hiscock 4,552.00p 11 £500.72
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 297,088 £7,204,384
Ian James Nicholson 13,000 £315,250
Bruce Hiscock 1,174 £28,470

Major Shareholders

Notifier** Holding Value*
Rathbones Investment Management Ltd 5,219,656 £126,576,658
Castlefield Fund Partners Limited 985,000 £23,886,250
SANFORD DELAND ASSET MANAGEMENT LTD 885,000 £21,461,250
Gresham House Asset Management Limited 627,782 £15,223,714
SANFORD DELAND ASSET MANAGEMENT LTD 619,500 £15,022,875
Miton Group plc 508,135 £12,322,274
The Diverse Income Trust plc 302,300 £7,330,775
Schroders plc 284,795 £6,906,279
Wasatch Advisors, Inc. 265,000 £6,426,250
Canaccord Genuity Group Inc 259,940 £6,303,545
Adrian Williams 253,372 £6,144,271

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,425.00p
Change Today 5.00p
% Change 0.21 %
52 Week High 4,750.00
52 Week Low 2,400.00
Volume 5,063
Shares Issued 5.22m
Market Cap £126.58m
Beta 0.00

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
39.09% below the market average39.09% below the market average39.09% below the market average39.09% below the market average39.09% below the market average
87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average
Price Trend
73.22% below the market average73.22% below the market average73.22% below the market average73.22% below the market average73.22% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Income
40.84% above the market average40.84% above the market average40.84% above the market average40.84% above the market average40.84% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
26.24% below the market average26.24% below the market average26.24% below the market average26.24% below the market average26.24% below the market average
29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 01-Apr-2025

Time Volume / Share Price
16:49 1,100 @ 2,416.30p
16:38 1,000 @ 2,400.00p
16:29 10 @ 2,407.00p
16:05 10 @ 2,410.00p
15:17 10 @ 2,413.44p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page